Patent · US Active

Triple glucagon/GLP-1/GIP receptor agonist

US11332508B2 · kind B2 · utility

0Cited by
10References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2019
Grant dateMay 17, 2022
Priority date—
Expiry dateMar 29, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors is disclosed. Uses of the triple agonist are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.